We recently showed that ACC expresses Ptch1 and that the first Ptch1 drug efflux inhibitor identified from our screening of the Prestwick Chemical library, methiothepin, was able to increase the efficacy of doxorubicin against the human ACC cell line H295R [13]. The gene discussed is PTCH1; the disease is adrenal cortex carcinoma.